Alibaba
BABA
Broadcom
AVGO
ASML Holding
ASML
Tesla
TSLA
Micron Technology
MU
US Stock MarketDetailed Quotes
KNSA Kiniksa Pharmaceuticals International
- 21.080
- +0.220+1.05%
Trading Mar 11 09:30 ET
1.53BMarket Cap-35.13P/E (TTM)
21.245High20.750Low5.27KVolume20.750Open20.860Pre Close110.21KTurnover0.02%Turnover RatioLossP/E (Static)72.64MShares28.15052wk High3.49P/B490.25MFloat Cap16.56052wk Low--Dividend TTM23.26MShs Float32.880Historical High--Div YieldTTM2.37%Amplitude5.010Historical Low20.924Avg Price1Lot Size
Kiniksa Pharmaceuticals International Key Stats
EPS
According to the latest financial report of Kiniksa Pharmaceuticals International, the latest earnings per share (TTM) for the company is -0.12. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Kiniksa Pharmaceuticals International's free cash flow? The latest report shows it as 18.58M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Kiniksa Pharmaceuticals International shows that the company's current ratio is 3.30, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Kiniksa Pharmaceuticals International, the quick ratio is 2.84, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Kiniksa Pharmaceuticals International? The latest ROE figure is -2.03%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Kiniksa Pharmaceuticals International, the total asset return on investment (ROA) is -1.57%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Kiniksa Pharmaceuticals International's latest financial report to see how their gross margin is doing - currently at 150.78%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Kiniksa Pharmaceuticals International, the net profit margin is -7.25%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.